DYNLRB1 and cancer: Multiple stromal cells and ECM components of the TME are extensively disrupted following bLP-mediated PTT, resulting in a 4.27-fold increase in the secondary accumulation of bLP in tumors, deep penetration throughout the tumor block, and a 27.0-fold increase in cancer cell accessibility.